123 related articles for article (PubMed ID: 34626598)
1. Scorpion bradykinin potentiating factor mitigates lung damage induced by γ-irradiation in rats: Insights on AngII/ACE/Ang(1-7) axis.
Hasan HF; Mohmed HK; Galal SM
Toxicon; 2021 Nov; 203():58-65. PubMed ID: 34626598
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin-potentiating factor isolated from Leiurus quinquestriatus scorpion venom alleviates cardiomyopathy in irradiated rats via remodelling of the RAAS pathway.
Hasan HF; Radwan RR; Galal SM
Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):263-273. PubMed ID: 31664738
[TBL] [Abstract][Full Text] [Related]
3. Mitigative impact of bradykinin potentiating factor isolated from
Hasan HF; Galal SM; Ellethy RA
Toxicol Mech Methods; 2022 Sep; 32(7):518-529. PubMed ID: 35253586
[TBL] [Abstract][Full Text] [Related]
4. Diminazene aceturate extenuate the renal deleterious consequences of angiotensin-II induced by γ-irradiation through boosting ACE2 signaling cascade.
Hasan HF; Elgazzar EM; Mostafa DM
Life Sci; 2020 Jul; 253():117749. PubMed ID: 32380079
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
7. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic angiotensin converting enzyme inhibition on angiotensin I and bradykinin metabolism in rats.
Stanziola L; Greene LJ; Santos RA
Am J Hypertens; 1999 Oct; 12(10 Pt 1):1021-9. PubMed ID: 10560789
[TBL] [Abstract][Full Text] [Related]
9. ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin.
Wösten-van Asperen RM; Lutter R; Haitsma JJ; Merkus MP; van Woensel JB; van der Loos CM; Florquin S; Lachmann B; Bos AP
Eur Respir J; 2008 Feb; 31(2):363-71. PubMed ID: 17959639
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue.
Campbell DJ; Duncan AM; Kladis A
Hypertension; 1999 Aug; 34(2):171-5. PubMed ID: 10454436
[TBL] [Abstract][Full Text] [Related]
11. Balancing Effect of Biejiajian Oral Liquid () on ACE-Ang II-AT1R Axis and ACE2-Ang-(1-7)-Mas Axis in Rats with CCl
Li XY; Peng Y; Bu XW; Yao J; Yao L
Chin J Integr Med; 2018 Nov; 24(11):853-859. PubMed ID: 29335866
[TBL] [Abstract][Full Text] [Related]
12. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
[TBL] [Abstract][Full Text] [Related]
13. Outcome of venom bradykinin potentiating factor on rennin-angiotensin system in irradiated rats.
Ashry O; Moustafa M; Baset AA; Abu Sinna GE; Farouk H
Int J Radiat Biol; 2012 Nov; 88(11):840-5. PubMed ID: 22852795
[TBL] [Abstract][Full Text] [Related]
14. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
Campbell DJ; Kladis A; Duncan AM
Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
[TBL] [Abstract][Full Text] [Related]
15. Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme.
Campbell DJ; Kladis A; Valentijn AJ
J Cardiovasc Pharmacol; 1995 Aug; 26(2):233-40. PubMed ID: 7475048
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation.
Li Y; Zeng Z; Li Y; Huang W; Zhou M; Zhang X; Jiang W
Shock; 2015 Apr; 43(4):395-404. PubMed ID: 25768373
[TBL] [Abstract][Full Text] [Related]
17. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.
Chappell MC; Pirro NT; Sykes A; Ferrario CM
Hypertension; 1998 Jan; 31(1 Pt 2):362-7. PubMed ID: 9453329
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
[TBL] [Abstract][Full Text] [Related]
20. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
